ABSTRACT
IMPORTANCE Children exposed to a high level of prenatal alcohol exposure (PAE) are more likely to develop fetal alcohol spectrum disorder with adverse phenotypes on their faces. However, it is still poorly understood, which level of PAE is associated with facial manifestation and if such associations persist during childhood.
OBJECTIVE To examine the association between PAE and children’s facial phenotype in a prospective multi-ethnic population-based study.
DESIGN, SETTING, AND PARTICIPANTS This study was based on the Generation R Study, a prospective cohort from fetal life onwards with maternal and offspring data. Children had a 3D facial image taken at ages 9 (n=3160) and 13 years (n=2492).
EXPOSURES We defined 6 levels of PAE based on the frequency and dose of alcohol consumption, and defined three tiers based on the timing of alcohol exposure of the unborn child.
MAIN OUTCOMES AND MEASURES For image analysis, we used 3D graph convolutional networks for non-linear dimensionality reduction, which compressed the high-dimensional images into 200 endophenotypes representing facial morphology. These facial endophenotypes were used as dependent variables in a linear regression analysis to search for associations with PAE. Finally, to detect specific facial components associated with PAE, we mapped statistically significant endophenotypes back to the 3D facial shape. We generated heatmaps to display the facial changes associated with PAE. PAE prediction based on facial shape was also performed; the prediction accuracy was estimated by area under the receiver operating characteristic curve (AUC).
RESULTS A significant association between PAE and facial shape was found in the 9-year-old children, at all levels of alcohol exposure: the higher the level of exposure, the stronger the association. Moreover, PAE before and during pregnancy was associated with facial shape. The most common detected facial phenotypes included turned-up nose tip, shortened nose, turned-out jaw and turned-in lower-eyelid-related regions. For the 13-year-old children, the associations were weaker and the AUCs lower than those of the 9-years-old children.
CONCLUSIONS AND RELEVANCE PAE before and during pregnancy, even at low level, is associated with the facial shape of children, and these associations become weaker as children grow older.
Questions Which level of prenatal alcohol exposure (PAE) is associated with children’s facial shape at different lifetimes?
Findings A 3D facial phenotype analysis of 9- (N=3160) and 13- (N=2492) year-old children was conducted. PAE before and during pregnancy, even at low level, associates with the children’s facial shape; the association becomes weaker as children grow older.
Meaning The results suggest avoiding drinking alcohol at least three months before and during pregnancy is the safest option for the child. More research is needed to investigate the consequences of PAE on children; the discovered facial phenotypes could be used as a biomarker for further investigations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
- European Reference Network on Cranial diseases
- European Commission Cost Action: GEnomics of MusculoSkeletal traits TranslatiOnal Network (CA86139) https://www.cost.eu/actions/CA18139/
- European Commission MSC-ITN Tissue engineering in osteoarthritis and bone disease https://www.carbonresearch.eu.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Medical Ethics Committee (MEC) of the Erasmus Medical Center
Rotterdam, The Netherlands (MEC 198.782/2001/31), and written informed consent was obtained from all participants themselves, or on that of their guardians/parents.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
private data from the Generation R study
